Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 20,435Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1DR REDDYS

02 1ACCORD HLTHCARE

03 1APOTEX

04 1ARTHUR GRP

05 1ASPIRO

06 1BAXTER HLTHCARE CORP

07 1BE PHARMS

08 1CHIA TAI TIANQING

09 1EUGIA PHARMA

10 1FRESENIUS KABI USA

11 1GENEYORK PHARMS

12 1LUPIN LTD

13 2MERCK AND CO INC

14 1MSN

15 2MYLAN LABS LTD

16 1NAVINTA LLC

17 1PIRAMAL CRITICAL

18 1QILU PHARM HAINAN

19 1SAGENT PHARMS

20 1SANDOZ

21 1STERISCIENCE

22 1TEVA PHARMS USA

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

RLD : No

TE Code : AP

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Approval Date : 2020-12-09

Application Number : 211160

RX/OTC/DISCN : RX

RLD : No

TE Code : AP

Dr Reddy Company Banner

02

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Approval Date : 2020-08-26

Application Number : 204025

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

03

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Approval Date : 2019-09-05

Application Number : 205020

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

04

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Approval Date : 2016-06-09

Application Number : 206197

RX/OTC/DISCN : RX

RLD : No

TE Code : AP

blank

05

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : EMEND

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 115MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date : 2008-01-25

Application Number : 22023

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

blank

06

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : EMEND

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Approval Date : 2010-11-12

Application Number : 22023

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AP

blank

07

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : UNKNOWN

Dosage Strength : UNKNOWN

Approval Date :

Application Number : 204845

RX/OTC/DISCN :

RLD :

TE Code :

blank

08

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Approval Date : 2020-12-08

Application Number : 203939

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

09

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 115MG BASE/VIAL

Approval Date : 2019-09-05

Application Number : 204015

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

10

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Approval Date : 2019-09-05

Application Number : 204015

RX/OTC/DISCN : RX

RLD : No

TE Code : AP

blank